Monday, July 13, 2026
Preview mode — showing bulk-ingested data not yet promoted to production. Hide preview

TGA / PMDA / NMPA · Asia-Pacific

clam — TGA / PMDA / NMPA regulatory status

clam regulatory status in the Asia-Pacific is tracked from public TGA / PMDA / NMPA records and cross-linked clinical and patent datasets on NovaPharmaNews. Current status: NMPA clinical trials.

Status snapshot

Status
NMPA clinical trials
Structured fields
4

Regional decision snapshot — NMPA: clinical trials.

Linked evidence on this spoke: 7 published clinical programs and 3 related patent records. Use the tables below for NCT identifiers, phases, and exclusivity dates; verify against primary sources before BD or medical decisions.

Regulatory timeline

Regulator Region Status Date Source
NMPA China clinical trials Evidence

Linked clinical programs

Related patents

Number Title Jurisdiction
12259378 Dynamic clamps and methods of use thereof US
2016030472 XENON-BASED ANESTHETIC GAS COMPOSITION USABLE DURING AN ENDARTERECTOMY INVOLVING THE CLAMPING OF THE CAROTID ARTERY US
2964876 COMPOSITION ANESTHESIQUE GAZEUSE A BASE DE XENON UTILISABLE PENDANT UNE ENDARTERIECTOMIE AVEC CLAMPAGE DE L'ARTERE CAROTIDE FR

Related hubs

FAQ

What is the TGA / PMDA / NMPA approval status of clam?

clam currently shows NMPA clinical trials in our Asia-Pacific regulatory index. Confirm on the official TGA / PMDA / NMPA label or EPAR before clinical or commercial use.

Where does NovaPharmaNews get clam regulatory data?

Status fields are joined from public sources (openFDA / EMA / regional agencies), ClinicalTrials.gov-linked programs, and patent registries. See /about/data-sources for attribution.

How many clinical programs are linked to clam?

This spoke lists 7 published programs associated with clam in our pipeline index.